Latest Commercialization News

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

AXP Energy has secured $1.25 million through a share placement to accelerate its modular data centre rollout powered by stranded natural gas in Colorado. This capital injection aims to support the company’s pioneering gas-to-power operations tied to Bitcoin mining and other high-performance computing applications.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Gold Hydrogen Limited has secured a $6.45 million R&D tax refund, strengthening its financial position ahead of an ambitious 2025 drilling campaign. The company also announced key leadership changes, including the appointment of a seasoned Chief Geologist.

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Nufarm Limited’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strong growth in omega-3 canola and strategic cost-saving initiatives setting the stage for future expansion.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

WAT Resources Ltd has successfully produced ferroniobium from its Luni niobium concentrate, marking a key milestone in the West Arunta Project’s development. The proof-of-concept testwork confirms the viability of a conventional production process and sets the stage for further optimisation and product diversification.

Entyr Limited has received a $3.79 million R&D tax incentive payment for its innovative thermal desorption project targeting rubber waste, reinforcing its position in sustainable tyre recycling technology.